↓ Skip to main content

Cancer Drug Resistance

Overview of attention for book
Cancer Drug Resistance
Springer New York

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Cancer Drug Resistance: A Brief Overview from a Genetic Viewpoint
  3. Altmetric Badge
    Chapter 2 Classical and Targeted Anticancer Drugs: An Appraisal of Mechanisms of Multidrug Resistance.
  4. Altmetric Badge
    Chapter 3 In Vitro Methods for Studying the Mechanisms of Resistance to DNA-Damaging Therapeutic Drugs.
  5. Altmetric Badge
    Chapter 4 In Vitro Approaches to Study Regulation of Hepatic Cytochrome P450 (CYP) 3A Expression by Paclitaxel and Rifampicin.
  6. Altmetric Badge
    Chapter 5 Uptake and Permeability Studies to Delineate the Role of Efflux Transporters.
  7. Altmetric Badge
    Chapter 6 Dynamics of Expression of Drug Transporters: Methods for Appraisal.
  8. Altmetric Badge
    Chapter 7 Fluorimetric Methods for Analysis of Permeability, Drug Transport Kinetics, and Inhibition of the ABCB1 Membrane Transporter
  9. Altmetric Badge
    Chapter 8 Resistance to Targeted Therapies in Breast Cancer.
  10. Altmetric Badge
    Chapter 9 MicroRNAs and Cancer Drug Resistance
  11. Altmetric Badge
    Chapter 10 The Role of MicroRNAs in Resistance to Current Pancreatic Cancer Treatment: Translational Studies and Basic Protocols for Extraction and PCR Analysis
  12. Altmetric Badge
    Chapter 11 Methods for Studying MicroRNA Expression and Their Targets in Formalin-Fixed, Paraffin-Embedded (FFPE) Breast Cancer Tissues
  13. Altmetric Badge
    Chapter 12 The Regulatory Role of Long Noncoding RNAs in Cancer Drug Resistance
  14. Altmetric Badge
    Chapter 13 Cancer Exosomes as Mediators of Drug Resistance.
  15. Altmetric Badge
    Chapter 14 Isolation and Characterization of Cancer Stem Cells from Primary Head and Neck Squamous Cell Carcinoma Tumors
  16. Altmetric Badge
    Chapter 15 Clinical and Molecular Methods in Drug Development: Neoadjuvant Systemic Therapy in Breast Cancer as a Model.
  17. Altmetric Badge
    Chapter 16 Proteomics in the Assessment of the Therapeutic Response of Antineoplastic Drugs: Strategies and Practical Applications.
  18. Altmetric Badge
    Chapter 17 Managing Drug Resistance in Cancer: Role of Cancer Informatics
  19. Altmetric Badge
    Chapter 18 Erratum to: In Vitro Methods for Studying the Mechanisms of Resistance to DNA-Damaging Therapeutic Drugs
Attention for Chapter 15: Clinical and Molecular Methods in Drug Development: Neoadjuvant Systemic Therapy in Breast Cancer as a Model.
Altmetric Badge

Readers on

mendeley
12 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Clinical and Molecular Methods in Drug Development: Neoadjuvant Systemic Therapy in Breast Cancer as a Model.
Chapter number 15
Book title
Cancer Drug Resistance
Published in
Methods in molecular biology, January 2016
DOI 10.1007/978-1-4939-3347-1_15
Pubmed ID
Book ISBNs
978-1-4939-3345-7, 978-1-4939-3347-1
Authors

Sofia Braga

Editors

José Rueff, António Sebastião Rodrigues

Abstract

Neoadjuvant chemotherapy (NACT), neoadjuvant endocrine therapy (NAET), and neoadjuvant targeted therapy (NATT), more recently, have been adopted worldwide as standard of care in locally advanced and inoperable BC. These modalities, collectively called neoadjuvant systemic therapy (NAST), are also used for organ preservation and for mechanistic biological studies on drug response and resistance, drug development, and clinical trials. Furthermore, the response to NACT is a valuable indicator of long-term survival. In this work, the advantages and pitfalls of using NAST in BC for studying drug response and resistance for drug development and clinical trials are discussed as well as practical points on how to set up a NAST clinical trial in BC.

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 8%
Germany 1 8%
Unknown 10 83%

Demographic breakdown

Readers by professional status Count As %
Other 2 17%
Student > Doctoral Student 2 17%
Librarian 1 8%
Student > Bachelor 1 8%
Lecturer 1 8%
Other 3 25%
Unknown 2 17%
Readers by discipline Count As %
Medicine and Dentistry 3 25%
Agricultural and Biological Sciences 2 17%
Nursing and Health Professions 1 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 8%
Design 1 8%
Other 0 0%
Unknown 4 33%